Dexmedetomidine protects against apoptosis induced by hypoxia/reoxygenation through the inhibition of gap junctions in NRK-52E cells

Life Sci. 2015 Feb 1:122:72-7. doi: 10.1016/j.lfs.2014.12.009. Epub 2014 Dec 19.

Abstract

Aims: The α2-adrenoceptor inducer dexmedetomidine (Dex) provides renoprotection against ischemia/reperfusion (I/R) injury, but the mechanism of this effect is largely unknown. The present study investigated the effect of Dex on apoptosis induced by hypoxia/reoxygenation (H/R) and the relationship between this effect and gap junction intercellular communication (GJIC).

Main methods: In vitro, two cell lines of normal rat kidney proximal tubular cells (NRK-52E) and HeLa cells that were transfected with a connexin 32 (Cx32) plasmid were exposed to H/R. The role of Dex in the modulation of H/R-induced apoptosis was explored by the manipulation of connexin expression, and hence gap junction (GJ) function, using a GJIC inhibitor, heptanol, and a GJIC inducer, retinoic acid. GJ function and the Cx32 protein level were determined by the parachute dye-coupling assay and Western blotting, respectively.

Key findings: Dex and heptanol significantly reduced H/R-induced apoptosis in NRK-52E cells. The anti-apoptosis effect of Dex was exhibited only in Cx32-expressing HeLa cells. One hour Dex exposure inhibited GJ function mainly via a decrease in Cx32 protein levels in NRK-52E cells.

Significance: Our data suggest that Dex reduced H/R-induced apoptosis through the inhibition of GJ activity by reducing Cx32 protein levels.

Keywords: Apoptosis; Dexmedetomidine; Gap junction intercellular communication; HeLa cell; Hypoxia/reoxygenation; NRK-52E cell.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic alpha-2 Receptor Agonists / pharmacology
  • Animals
  • Apoptosis / drug effects*
  • Blotting, Western
  • Cell Communication / drug effects*
  • Cell Proliferation / drug effects
  • Cells, Cultured
  • Dexmedetomidine / pharmacology*
  • Flow Cytometry
  • Gap Junctions / drug effects*
  • HeLa Cells
  • Humans
  • Hypoxia / physiopathology*
  • Kidney Tubules / drug effects
  • Kidney Tubules / metabolism
  • Kidney Tubules / pathology*
  • Male
  • Oxygen / pharmacology*
  • Protective Agents / pharmacology*
  • Rats
  • Reperfusion Injury / drug therapy
  • Reperfusion Injury / metabolism
  • Reperfusion Injury / pathology
  • Signal Transduction

Substances

  • Adrenergic alpha-2 Receptor Agonists
  • Protective Agents
  • Dexmedetomidine
  • Oxygen